Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-1,41%
1 076,13
-15,38
-1,41%
—1 091,511 090,401 090,401 073,69——
SIXC
Communications
SIXC
Communications
SIXC
-0,55%
606,74
-3,37
-0,55%
—610,11610,11610,29606,17——
SIXE
Energy
SIXE
Energy
SIXE
+0,88%
1 248,82
+10,84
+0,88%
—1 237,981 237,831 252,411 225,03——
SIXI
Industrials
SIXI
Industrials
SIXI
-1,17%
1 724,36
-20,35
-1,17%
—1 744,711 740,951 747,291 721,57——
SIXM
Financials
SIXM
Financials
SIXM
-0,72%
635,59
-4,59
-0,72%
—640,18639,92643,19634,73——
SIXR
Staples
SIXR
Staples
SIXR
-0,76%
843,15
-6,43
-0,76%
—849,58845,27851,68839,47——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0,55%
216,29
-1,19
-0,55%
—217,48217,48218,16215,51——
SIXT
Technology
SIXT
Technology
SIXT
+0,08%
3 263,41
+2,72
+0,08%
—3 260,693 273,363 287,813 240,78——
SIXU
Utilities
SIXU
Utilities
SIXU
-0,34%
939,24
-3,21
-0,34%
—942,45939,39948,80933,98——
SIXV
Health care
SIXV
Health care
SIXV
-0,29%
1 462,56
-4,24
-0,29%
—1 466,801 464,701 467,191 458,36——
SIXY
Discretionary
SIXY
Discretionary
SIXY
-0,71%
2 380,40
-17,10
-0,71%
—2 397,502 395,032 412,012 370,64——
MVR0:FRA
Medivir AB
0,14 €
-12,69%
(-0,020) 1D
4-май, 22:00:00 GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for MVR0...
Open
0,14 €
High
0,15 €
Low
0,14 €
Mkt. cap
1,01 млд
Avg. vol.
21,00
Volume
0,00
52-wk high
0,26 €
52-wk low
0,00 €
No. of employees
10
News stories
From sources across the web
Profile
Medivir is a Swedish biotech company. Medivir focuses its research focus on oncology and particularly on innovative pharmaceuticals that meet substantial unmet medical needs. The pharmaceutical development work is conducted both in-house and through partnerships, usually with global pharmaceutical companies. Medivir has a leading expertise in the design of protease inhibitors and in the science of nucleotides and nucleosides. Medivir is listed on the Nasdaq Stockholm Mid Cap List. In February 2020, Medivir announced that the company has signed a licensing agreement for Xerclear with Chinese company Shijiazhuang Yuanmai Biotechnology Co Ltd. The agreement gives SYB the right to register, manufacture and market the product in China. Wikipedia
About Medivir AB
CEOChristine Lind
Employees10
Founded1988
Headquarters-
Sector-
Websitemedivir.com
Previous reportsAll values in SEK
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in SEK
2025-ж. мар.
2025-ж. июн.
2025-ж. сен.
2025-ж. дек.
Revenue
600,00 миң
1,50 млн
1,00 млн
5,51 млн
Cost of goods sold
6,10 млн
17,00 млн
8,10 млн
10,21 млн
Cost of revenue
6,10 млн
17,00 млн
8,10 млн
10,21 млн
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
7,00 млн
7,10 млн
5,80 млн
7,16 млн
Operating expense
8,10 млн
7,60 млн
6,50 млн
37,66 млн
Total operating expenses
14,20 млн
24,60 млн
14,60 млн
47,88 млн
Operating income
-13,60 млн
-23,10 млн
-13,60 млн
-42,37 млн
Other non operating income
200,00 миң
-
-
-500,00 миң
EBT including unusual items
-13,30 млн
-23,30 млн
-14,60 млн
-43,20 млн
EBT excluding unusual items
-13,30 млн
-23,30 млн
-14,60 млн
-43,77 млн
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
400,00 миң
-200,00 миң
-
-7,00 миң
Net income
-13,30 млн
-23,30 млн
-14,60 млн
-43,20 млн
Net profit margin
-2 216,67%
-1 553,33%
-1 460,00%
-784,60%
Earnings per share
-0,12
-0,20
-0,13
-
Interest and investment income
100,00 миң
-
-
41,00 миң
Interest expense
-
-200,00 миң
-1,00 млн
-1,31 млн
Net interest expenses
100,00 миң
-200,00 миң
-1,00 млн
-1,27 млн
Depreciation and amortization charges
700,00 миң
700,00 миң
700,00 миң
30,51 млн
EBITDA
-12,90 млн
-22,40 млн
-12,90 млн
-11,87 млн
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer